DERCOS DS – 2024 STUDIES COMPENDIUM

  • 10min
  • Apr. 2024
  • Supported by
  • Dercos

AVAILABLE NOW!


N°1 Anti-dandruff dermocosmetic brand recommended by dermatologists worldwide*.

Your efficacy ally to treat the full spectrum of seborrheic dermatitis for ultimate efficacy & cosmeticity, leading to the highest patient satisfaction & adherence.
Clinically-proven efficacy as monotherapy on mild to severe dandruff and seborrheic dermatitis.
Clinically-proven efficacy as maintainance & adjunctive therapy.
Clinically tested on all ages**, all hair types and all scalp types.
Proven in real-life conditions: observational studies’ results on more than 7500 subjects, by 337 dermatologists, in 37 countries.

* Survey conducted among the dermo cosmetic market carried out by APLUSA and its partners between June 2023 and September 2023, involving on 2 871 board-certified dermatologists in 29 countries, representing more than 80% of the worldwide GDP. “What is the dermocosmetic brand that you most often recommend or prescribe for dandruff?”
**Adolescents & Adults: 12 to 94 years old, Worldwide Observational Study conducted in 32 countries
DERCOS DS Compendium